EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Combating Antimicrobial Resistance: Innovative Strategies Using Peptides, Nanotechnology, Phages, Quorum Sensing Interference, and CRISPR-Cas Systems

Ana Cristina Jacobowski iD, Ana Paula Araújo Boleti, Maurício Vicente Cruz, Kristiane Fanti Del Pino Santos iD, Lucas Rannier Melo de Andrade iD, Breno Emanuel Farias Frihling, Ludovico Migliolo iD, Patrícia Maria Guedes Paiva, Paulo Eduardo Teodoro iD, Larissa Pereira Ribeiro Teodoro iD, Maria Lígia Rodrigues Macedo iD

Pharmaceuticals · 27.07.2025 · 18 (8) · 1119

DOI: 10.3390/ph18081119 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.07.2025. Verfasst von Ana Cristina Jacobowski und 10 weiteren Autor:innen. Beteiligte Einrichtung: Protein Purification and Biological Functions Laboratory, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso d…. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Financiadora de Estudos e Projetos, Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges of our time. Alarming projections of increasing mortality from resistant infections highlight the urgent need for innovative solutions. While many candidates have shown promise in preliminary studies, they often encounter challenges in terms of efficacy and safety during clinical translation. This review examines cutting-edge approaches to combat AMR, with a focus on engineered antimicrobial peptides, functionalized nanoparticles, and advanced genomic therapies, including Clustered Regularly Interspaced Short Palindromic Repeats-associated proteins (CRISPR-Cas systems) and phage therapy. Recent advancements in these fields are critically analyzed, with a focus on their mechanisms of action, therapeutic potential, and current limitations. Emphasis is given to strategies targeting biofilm disruption and quorum sensing interference, which address key mechanisms of resistance. By synthesizing current knowledge, this work provides researchers with a comprehensive framework for developing next-generation antimicrobials, highlighting the most promising approaches for overcoming AMR through rational drug design and targeted therapies. Ultimately, this review aims to bridge the gap between experimental innovation and clinical application, providing valuable insights for developing effective and resistance-proof antimicrobial agents.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial peptidesbiofilm disruptioncombination therapiesdrug delivery systemsmultidrug resistance

Autor:innen und Institutionen

  • Protein Purification and Biological Functions Laboratory, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), P.O. Box 549, Campo Grande 79050-010, MS, Brazil.
  • Federal Institute of Education, Science and Technology of Goiás, Goiânia 74055-110, GO, Brazil.
  • Postgraduate Program in Biotechnology, Dom Bosco Catholic University, Campo Grande 79117-900, MS, Brazil.
  • Biochemistry Department, Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil.
  • Chapadão do Sul Campus, Federal University of Mato Grosso do Sul (UFMS), Chapadão do Sul 79560-000, MS, Brazil.

ORCID-Profile: Ana Cristina Jacobowski, Kristiane Fanti Del Pino Santos, Lucas Rannier Melo de Andrade, Ludovico Migliolo, Paulo Eduardo Teodoro, Larissa Pereira Ribeiro Teodoro, Maria Lígia Rodrigues Macedo

Förderung

  • National Council for Scientific and Technological Development
  • Financiadora de Estudos e Projetos
  • Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul
  • Universidade Federal de Mato Grosso do Sul
  • CNPq
  • FINEP
  • Fundect
  • Federal University of Mato Grosso do Sul-Brasil (UFMS)

Zitieren

APA

Jacobowski, A. C., Boleti, A. P. A., Cruz, M. V., Santos, K. F. D. P., de Andrade, L. R. M., Frihling, B. E. F., Migliolo, L., Paiva, P. M. G., Teodoro, P. E., Teodoro, L. P. R., & Macedo, M. L. R. (2025). Combating Antimicrobial Resistance: Innovative Strategies Using Peptides, Nanotechnology, Phages, Quorum Sensing Interference, and CRISPR-Cas Systems. Pharmaceuticals, 18(8), 1119. https://doi.org/10.3390/ph18081119

Vancouver

Jacobowski AC, Boleti APA, Cruz MV, Santos KFDP, de Andrade LRM, Frihling BEF, et al. Combating Antimicrobial Resistance: Innovative Strategies Using Peptides, Nanotechnology, Phages, Quorum Sensing Interference, and CRISPR-Cas Systems. Pharmaceuticals. 2025;18(8):1119. doi:10.3390/ph18081119

BibTeX
@article{Jacobowski2025,
  author = {Jacobowski, Ana Cristina and Boleti, Ana Paula Araújo and Cruz, Maurício Vicente and Santos, Kristiane Fanti Del Pino and de Andrade, Lucas Rannier Melo and Frihling, Breno Emanuel Farias and Migliolo, Ludovico and Paiva, Patrícia Maria Guedes and Teodoro, Paulo Eduardo and Teodoro, Larissa Pereira Ribeiro and Macedo, Maria Lígia Rodrigues},
  title = {Combating Antimicrobial Resistance: Innovative Strategies Using Peptides, Nanotechnology, Phages, Quorum Sensing Interference, and CRISPR-Cas Systems},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {8},
  pages = {1119},
  doi = {10.3390/ph18081119}
}
Kostenlos starten →